[Evaluation of the metabolic action of glucagon in subjects undergoing anti-insulin therapy].
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D003981:Diazoxide / Q000627:therapeutic use*; D005934:Glucagon / Q000494:pharmacology / Q000627:therapeutic use*; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006946:Hyperinsulinism / Q000188:drug therapy* / Q000209:etiology; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D010672:Phenytoin / Q000627:therapeutic use*; D011388:Prolactin / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D010672:Phenytoin; D011388:Prolactin; D013006:Growth Hormone; D005934:Glucagon; D003981:Diazoxide
Valutazione dell'azione metabolica del glucagone in soggetti sottoposti a terapia antinsulinica.